Quince therapeutics launches scientific advisory board

South san francisco, calif.--(business wire)---- $qncx--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient's own biology to deliver rare disease therapeutics, today announced the launch of a scientific advisory board (sab) comprised of leading experts in biochemistry, neurology, immunology, hematology, pharmacology, and clinical practice. “we are pleased to announce the formation of our scientific advisor.
QNCX Ratings Summary
QNCX Quant Ranking